デフォルト表紙
市場調査レポート
商品コード
1593457

ヘルスケア分析試験サービス市場規模、シェア、成長分析、タイプ別、エンドユーザー別、地域別 - 産業予測、2024年~2031年

Healthcare Analytical Testing Services Market Size, Share, Growth Analysis, By Type, By End User, By Region - Industry Forecast 2024-2031


出版日
発行
SkyQuest
ページ情報
英文 168 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヘルスケア分析試験サービス市場規模、シェア、成長分析、タイプ別、エンドユーザー別、地域別 - 産業予測、2024年~2031年
出版日: 2024年11月09日
発行: SkyQuest
ページ情報: 英文 168 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のヘルスケア分析試験サービス市場規模は、2022年に約66億5,000万米ドルと評価され、2023年の73億9,000万米ドルから上昇し、予測期間(2024-2031年)のCAGRは11.2%で、2031年には155億5,000万米ドルに達すると予測されます。

市場成長の背景には、分析試験を必要とする臨床試験数の増加、バイオシミラーへの注目の高まり、製薬企業による分析試験サービスのアウトソーシングへの顕著なシフトなど、いくつかの重要な要因があります。COVID-19パンデミックは、この市場の拡大に重要な役割を果たしました。当初は、自宅待機命令とサプライチェーンの混乱による減速を引き起こしましたが、最終的にはワクチンと治療に対する緊急の必要性により成長に拍車をかけました。例えば、2020年7月のSGS SAとAstraZenecaの提携は、COVID-19ワクチンAZD1222に不可欠な分析試験サービスの需要を例示し、このようなサービスがいかにリスク低減を促進し、品質保証を加速し、規制コンプライアンスを確保できるかを実証しました。特にバイオシミラー、配合剤、その他の新規治療薬の出現により、技術革新と検査サービス需要の増加との相関関係は明らかです。さらに、競争の激化、迅速な市場参入への圧力、価格設定の課題により、製薬企業はこれらの試験サービスのアウトソーシングを進めています。新市場への進出には、現地の規制要件を満たす必要もあり、その結果、特定の種類の検査に対するニーズが高まっています。高度で信頼性の高い分析試験への需要が急増し続ける中、市場は成長軌道を維持すると予想されます。

目次

イントロダクション

  • 調査の目的
  • 定義
  • 市場範囲

調査手法

  • 情報調達
  • 二次データソースと一次データソース
  • 市場規模予測
  • 市場の想定と制限

エグゼクティブサマリー

  • 市場概要見通し
  • 供給需要動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場力学
    • 促進要因
    • 機会
    • 抑制要因
    • 課題
  • ポーターの分析

主な市場の考察

  • 主な成功要因
  • 競合の程度
  • 主な投資機会
  • 市場のエコシステム
  • バリューチェーン分析
  • ケーススタディ分析
  • 規制情勢
  • スタートアップ分析
  • 技術分析
  • イノベーションマトリクス
  • 市場の魅力指数(2023年)

ヘルスケア分析試験サービス市場:タイプ別

  • 市場概要
  • 医療機器分析試験サービス
    • 抽出可能および浸出可能
    • 材料特性評価
    • 物理テスト
    • バイオバーデン試験
    • 無菌試験
    • その他
  • 医薬品分析試験サービス
    • 生体分析試験
    • 方法の開発と検証
    • 安定性テスト
    • その他の試験サービス

ヘルスケア分析試験サービス市場:エンドユーザー別

  • 市場概要
  • 製薬・バイオ医薬品企業
  • 医療機器企業
  • 病院・クリニック
  • 法医学研究所
  • 化粧品・栄養補助食品会社

ヘルスケア分析試験サービス市場規模:地域別

  • 市場概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ(MEA)
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ地域

競合情勢

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2023年)
  • 主な市場企業が採用した戦略
  • 市場における最近の活動
  • 主要企業の市場シェア(2023年)

主要企業プロファイル

  • Eurofins Scientific(Luxembourg)
  • Laboratory Corporation of America Holdings(US)
  • SGS S.A.(Switzerland)
  • Charles River Laboratories(US)
  • WuXi AppTec Co. Ltd.(China)
  • Element Materials Technology(UK)
  • Thermo Fisher Scientific, Inc.(US)
  • Pace Analytical Services LLC(US)
  • Intertek Group plc(UK)
  • IQVIA Inc.(US)
  • Merck KGaA(Germany)
  • Source BioScience(UK)
  • Almac Group(UK)
  • ICON Plc(Ireland)
  • Frontage Laboratories, Inc.(US)
  • STERIS Plc(US)
  • Sartorius AG(Germany)
  • ALS Life Science(US)
  • Syneos Health, INC(US)
  • Medpace Holdings, Inc.(US)
目次
Product Code: SQMIG35D2273

Global Healthcare Analytical Testing Services Market size was valued at around USD 6.65 billion in 2022 and is expected to rise from USD 7.39 billion in 2023 to reach a value of USD 15.55 billion by 2031, at a CAGR of 11.2% over the forecast period (2024-2031).

Market growth is driven by several key factors, including a rising number of clinical trials necessitating analytical testing, an increasing focus on biosimilars, and a notable shift towards outsourcing analytical testing services by pharmaceutical companies. The COVID-19 pandemic has played a significant role in this market's expansion; initially causing a slowdown due to stay-at-home orders and disruptions in supply chains, it ultimately spurred growth due to the urgent need for vaccines and treatments. For instance, the collaboration between SGS SA and AstraZeneca in July 2020 exemplified the demand for analytical testing services crucial for the COVID-19 vaccine AZD1222, demonstrating how such services can facilitate risk reduction, accelerate quality assurance, and ensure regulatory compliance. The correlation between innovations and the increased demand for testing services is evident, especially with the advent of biosimilars, combination products, and other novel therapeutics. Furthermore, intensified competition, pressures for quicker market entry, and pricing challenges are driving pharmaceutical firms to outsource these testing services. Expansion into new markets also necessitates meeting local regulatory requirements, resulting in an increased need for specific testing types. As demand for advanced and reliable analytical testing continues to surge, the market is expected to maintain its growth trajectory.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Healthcare Analytical Testing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Healthcare Analytical Testing Services Market Segmental Analysis

Global Healthcare Analytical Testing Services Market is segmented by Type, End User, and Region. Based on Type, the market is segmented into Medical Device Analytical Testing Services (Extractable and Leachable, Material Characterization, Physical Testing, Bioburden Testing, Sterility Testing, Others), Pharmaceutical Analytical Testing Services (Bioanalytical Testing, Method Development & Validation, Stability Testing, Other Testing Services). Based on End User, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Medical Device Companies, Hospitals & Clinics, Forensic Labs, Cosmetic & Nutraceutical Companies. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market is significantly driven by the rising demand for medical testing services, fueled by the surging aging population and the escalating prevalence of chronic diseases. This demand is further amplified by the advent of personalized medicine, which relies on sophisticated diagnostic testing and analytical services for tailored treatment approaches. Additionally, substantial investments from healthcare professionals and the biopharmaceutical sector in enhancing analytical testing capabilities have provided robust momentum to the market. As the necessity for accurate and dependable diagnostic results intensifies, the ongoing expansion and adoption of healthcare testing services are expected to persist, bolstering market growth.

Restraints in the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market faces significant restraints primarily due to high pricing and operational complexity. The cost associated with advanced analytical testing, which includes specialized software, sophisticated equipment, and the necessity for expert personnel, can deter small and medium-sized enterprises from investing in these essential services. Moreover, the intricate nature of testing processes compounds the risk of errors and inconsistencies, potentially undermining the integrity of results. This financial and operational burden makes it challenging for smaller firms to compete effectively, ultimately stunting market growth as stakeholders must carefully consider the balance between investment costs and anticipated benefits.

Market Trends of the Global Healthcare Analytical Testing Services Market

The Global Healthcare Analytical Testing Services market is witnessing a significant shift towards outsourcing, driven by cost reduction, technological advancements, and a focus on core competencies among biotechnology and pharmaceutical firms. As companies seek to enhance productivity and streamline operations, they increasingly turn to specialized service providers for analytical testing, allowing them to leverage external expertise and accelerate turnaround times. This trend is expected to grow, fueled by a rising demand for comprehensive analytical testing services that meet strict regulatory standards. Consequently, the outsourcing model is reshaping the market landscape, fostering innovation and efficiency in the healthcare sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Value Chain Analysis
  • Case Study Analysis
  • Regulatory Landscape
  • Startup Analysis
  • Technology Analysis
  • Innovation Matrix
  • Market Attractiveness Index, 2023

Healthcare Analytical Testing Services Market, By Type

  • Market Overview
  • Medical Device Analytical Testing Services
    • Extractable and Leachable
    • Material Characterization
    • Physical Testing
    • Bioburden Testing
    • Sterility Testing
    • Others
  • Pharmaceutical Analytical Testing Services
    • Bioanalytical Testing
    • Method Development & Validation
    • Stability Testing
    • Other Testing Services

Healthcare Analytical Testing Services Market, By End User

  • Market Overview
  • Pharmaceutical & Biopharmaceutical Companies
  • Medical Device Companies
  • Hospitals & Clinics
  • Forensic Labs
  • Cosmetic & Nutraceutical Companies

Healthcare Analytical Testing Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Eurofins Scientific (Luxembourg)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Laboratory Corporation of America Holdings (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • SGS S.A. (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Charles River Laboratories (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • WuXi AppTec Co. Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Element Materials Technology (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Pace Analytical Services LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Intertek Group plc (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IQVIA Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Source BioScience (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Almac Group (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ICON Plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Frontage Laboratories, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • STERIS Plc (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sartorius AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ALS Life Science (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Syneos Health, INC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medpace Holdings, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments